Implantica reports that two independent surgeons presented their RefluxStop™ patient data at the 2023 Annual Swiss College of Surgeons Congress (SCS)
Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that two independent scientific presentations on RefluxStop™ patient data were delivered at the 2023 SCS meeting in Basel in June 7-9, 2023.RefluxStop™ was featured as part of this year’s scientific program: · RefluxStop™ - a novel device to address Gastroesophageal Reflux Disease in the context of esophageal hypomotility. Presented by: Dr. med. Yves Borbély, Visceral Surgery Specialist at Inselspital, the University Hospital of Bern, Switzerland Conclusion: